Search clinical trials for: Transitional cell, carcinoma
Total 30000 results
-
AnchorDx Medical Co., Ltd.The First Affiliated Hospital with Nanjing Medical University; Peking University... and other collaboratorsCompletedBladder Cancer | Urothelial CarcinomaChina
-
Centre Hospitalier Universitaire, AmiensCompletedUrothelial Carcinoma
-
The Methodist Hospital Research InstituteActive, not recruitingNon-Small Cell Lung Cancer | DNA Repair-Deficiency Disorders | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma Bladder | Classical Hodgkin Lymphoma | Malignant MelanomaUnited States
-
4D pharma plcWithdrawnUrothelial CarcinomaUnited States
-
Bristol-Myers SquibbWithdrawnMelanoma | Urothelial CarcinomaGermany, Spain
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLCCompletedUrothelial Carcinoma | Castration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Bladder Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage III Urethral Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Stage IV Urethral... and other conditionsUnited States
-
Matthew GalskyAstraZenecaActive, not recruitingUrothelial CarcinomaUnited States
-
Jens NielsenGöteborg UniversityCompletedBladder CancerSweden
-
Incyte CorporationCompletedUC (Urothelial Cancer)United States, Netherlands, Spain, Denmark, Belgium, Israel, Italy, Germany, France, Japan, United Kingdom
-
Hoffmann-La RocheCompletedUrothelial CarcinomaArgentina
-
Nektar TherapeuticsBristol-Myers SquibbCompletedMelanoma | Renal Cell Carcinoma | Gastric Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Urothelial Carcinoma | HR+/HER2- Breast CancerUnited States, Spain, Canada, France, Italy, Belgium, Poland, United Kingdom
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedTransitional Cell CarcinomaUnited States
-
MorphotekEisai Europe Ltd. (United Kingdom)TerminatedOvarian CancerUnited States, Hong Kong, Netherlands, Spain, Korea, Republic of, Belgium, Taiwan, Israel, Japan, France, United Kingdom, Singapore, Italy, Argentina, India, Germany, Hungary, Australia, Portugal, Russian Federation, Canada, Poland, Greec... and more
-
xCuresTerminatedTransitional Cell Carcinoma | Bladder Cancer | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | FGFR2 Gene Mutation | FGFR3 Gene Mutation | FGFR2 Amplification | Bladder Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Refractory Bladder Carcinoma | Refractory Bladder Urothelial Carcinoma and other conditionsUnited States
-
Arjun Balar, MDHoosier Cancer Research Network; Roche-GenentechTerminatedUrothelial CarcinomaUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedMetastatic Urothelial CarcinomaItaly
-
Infinity Pharmaceuticals, Inc.Bristol-Myers SquibbCompletedSolid Tumor | Bladder Cancer | Advanced Cancer | Urothelial CarcinomaFrance, Spain, United States, Italy, Czechia, Poland, Serbia
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedBladder Cancer | Metastatic Transitional Cell CarcinomaUnited States
-
Xiangya Hospital of Central South UniversityHunan Cancer Hospital; The Third Xiangya Hospital of Central South University; Hunan Provincial People's Hospital and other collaboratorsCompletedHigh-Grade Upper Tract Urothelial CarcinomaChina
-
AmgenTerminatedMelanoma | Cancer | Colorectal Cancer | Advanced Solid Tumors | Squamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung Cancer | Oncology | Tumors | Advanced Malignancy | Oncology Patients | Transitional Cell Carinoma of BladderBelgium, France, United States, Germany, Australia
-
Janssen Research & Development, LLCCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Fallopian Tube Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube... and other conditionsUnited States
-
Ludwig Institute for Cancer ResearchKrankenhaus NordwestCompletedMelanoma | Sarcoma | Breast Cancer | Head and Neck Cancer | Esophageal Cancer | Transitional Cell Carcinoma | Prostate Cancer | Ovarian Carcinoma | Gastrointestinal Stromal Tumor (GIST)Germany
-
Yousef ZakhariaPfizer; University of IowaActive, not recruitingUrothelial CarcinomaUnited States
-
Technical University of MunichBristol-Myers SquibbActive, not recruitingUrinary Bladder CancerGermany
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCActive, not recruitingRecurrent Bladder Carcinoma | Stage I Bladder Cancer | Stage 0a Bladder Urothelial Carcinoma | Stage 0is Bladder Urothelial CarcinomaUnited States
-
University of California, DavisMerck Sharp & Dohme LLCCompletedRecurrent Bladder Carcinoma | Stage III Urethral Cancer | Stage IV Urethral Cancer | Urethral Urothelial Carcinoma | Stage IV Bladder Urothelial Carcinoma | Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter | Stage III Bladder Urothelial Carcinoma | Recurrent Urothelial Carcinoma of... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedKidney Neoplasms | Urinary Bladder Neoplasms | Urothelial Carcinoma | Urethral NeoplasmsUnited States
-
Ludwig Institute for Cancer ResearchNational Cancer Institute (NCI)CompletedTransitional Cell CarcinomaUnited States
-
BayerCompletedCarcinoma, Transitional CellUnited States, Spain, Hungary, China, Belgium, Korea, Republic of, Taiwan, Australia, Singapore, Canada, Japan, Sweden, Russian Federation, Germany, Italy, Israel, Ireland, France, Austria, Denmark, Portugal, Switzerland, Czechia, Slo... and more
-
UroGen Pharma Ltd.CompletedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Israel
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCCompletedCarcinoma, Transitional Cell | Gastric Adenocarcinoma | Non-small Cell Lung Cancer | Biliary Tract Cancer | Adenocarcinoma of the Gastroesophageal JunctionGermany, United States, Spain, United Kingdom, France, Japan
-
GB006, Inc., a wholly owned subsidiary of Gossamer...Merck Sharp & Dohme LLCTerminatedRenal Cell Carcinoma | Hepatocellular Carcinoma | Pancreatic Adenocarcinoma | Gastric Adenocarcinoma | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Small-cell Lung Cancer | Castration-resistant Prostate Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal Adenocarcinoma | Esophageal... and other conditionsUnited States, United Kingdom
-
Guru P. SonpavdeQED Therapeutics, Inc.WithdrawnBladder Cancer | Bladder Transitional Cell Carcinoma | Fibroblast Growth Factor Receptor
-
Germans Trias i Pujol HospitalFundació Institut Germans Trias i Pujol; Spanish Clinical Research Network... and other collaboratorsCompletedUrothelial CarcinomaSpain
-
H. Lee Moffitt Cancer Center and Research InstituteAstraZenecaTerminatedBladder Cancer | Carcinoma in Situ of BladderUnited States
-
Sohag UniversityCompleted
-
Noah Hahn, M.D.Novartis Pharmaceuticals; Hoosier Cancer Research NetworkTerminatedBladder CancerUnited States
-
Noah Hahn, M.D.Hoosier Cancer Research Network; Achieve Life SciencesCompletedBladder Cancer | Urothelial CarcinomaUnited States
-
Hoosier Cancer Research NetworkBristol-Myers SquibbCompletedUrothelial CarcinomaUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedBladder CancerUnited States, Canada
-
Aprea TherapeuticsCompletedGastric Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Advanced Solid Tumor | Urothelial CarcinomaUnited States
-
Incyte CorporationTerminatedMetastatic Urothelial Carcinoma | Unresectable Urothelial CarcinomaSpain, France, United States, Italy, Japan, Ireland, Slovakia, Austria, Belgium, Canada, Finland, Germany, Poland, Portugal, Romania, United Kingdom
-
University of Turin, ItalyTesaro, Inc.Completed
-
University Health Network, TorontoCanadian Urological Association; Canadian Urologic Oncology Group; Bladder Cancer...TerminatedBladder Cancer | Bladder Urothelial CarcinomaCanada
-
Silverback TherapeuticsWithdrawnSquamous Cell Carcinoma of Head and Neck | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Urothelial Carcinoma | Hormone Receptor-positive/HER2-negative Breast Cancer
-
National Cancer Institute (NCI)TerminatedUrothelial CancerUnited States
-
Indiana UniversityTerminatedProstate Cancer | Urothelial CarcinomaUnited States
-
Samsung Medical CenterActive, not recruitingUrothelial CarcinomaKorea, Republic of
-
Emory UniversityTerminatedBladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Squamous Cell Carcinoma of the BladderUnited States